Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: moving on down the road.
Patterson
C
C
Runge
M S
MS
D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D003326:Coronary Circulation / Q000187:drug effects; D004562:Electrocardiography / Q000379:methods; D016228:Endothelial Growth Factors / Q000235:genetics* / Q000627:therapeutic use; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006321:Heart / Q000503:physiopathology; D006801:Humans; D008222:Lymphokines / Q000235:genetics* / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000503:physiopathology / Q000628:therapy*; D018919:Neovascularization, Physiologic; D013908:Thoracotomy; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D043925:Angiogenesis Inducing Agents; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors